Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

ISPE Singapore Affiliate Conference & Exhibition
23 - 25 August 2023
Times are shown in your local time zone GMT
Speaker Profile Image

Dr Richard Goodman

Director, Technical Development - GSK

Professional Bio

Richard Goodman is the technical director at GSK’s two API commercial manufacturing sites in Singapore. In this site leadership role he is responsible for the technical aspects of the sites’ manufacturing operations, including the tech transfer and validation of GSK’s small molecule New Chemical Entity (NCE) pipeline, along with process improvement programs, technical troubleshooting and lifecycle management for the sites’ established commercial products. His team also led the introduction of GSK’s first commercial API capability for both continuous manufacturing and synthetic biocatalysis, as well as the capability to manufacture highly potent APIs in a new high containment production facility.
Prior to this, Richard worked as a synthetic chemist in GSK’s R&D division outside Philadelphia, USA, where he led discovery and Quality by Design (QbD) process development of new NCE manufacturing routes for scale-up of clinical supplies and ultimately commercialization.
Richard completed his Ph.D. in Chemistry in the labs of Professor Yoshito Kishi at Harvard University in 1998, after receiving joint A.B./A.M. degrees in Chemistry from Harvard in 1992.